Cme (CME) Return on Equity (2009 - 2026)

Cme (CME) has 18 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Equity rose 48.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 48.0% YoY) and the FY2025 annual result came in at 0.0%, up 35.0% from the prior year.
• Return on Equity improved to 0.0% in Q1 2026 per CME's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Equity topped out at 1.27% in Q4 2022 and bottomed at 0.65% in Q3 2024.
• The 5-year median for Return on Equity is 0.0% (2025), against an average of 0.1%.
• The widest annual swing landed in 2022, when Return on Equity jumped 127 bps; it then tumbled 157 bps in 2023.
• Tracing CME's Return on Equity over 5 years: stood at 1.27% in 2022, then plunged by 124 bps to 0.31% in 2023, then sank by 42 bps to 0.44% in 2024, then jumped by 100 bps to 0.0% in 2025, then gained by 8 bps to 0.0% in 2026.
• Per Business Quant, the three latest CME Return on Equity figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison